IDEXX LaboratoriesSTU:IX1 -0.34%96 OCF Yield % is 2.83 as of Jun. 24, 2026, which is 40% above its 10-year median of 2.02. GuruFocus rates STU:IX1 with a GF Score™ of 96/100 and a GF Value™ of €553.33 (Modestly Undervalued). Among 215 Medical Diagnostics & Research companies, IDEXX Laboratories ranks better than 58.14% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for IDEXX Laboratories's OCF Yield % or its related term are showing as below:
STU:IX1'
s OCF Yield % Range Over the Past 10 Years
Min: 1.28 Med: 2.02 Max: 3.48
Current: 2.83
During the past 13 years, the highest OCF Yield % of IDEXX Laboratories was 3.48%. The lowest was 1.28%. And the median was 2.02%.
STU:IX1's OCF Yield % is ranked better than 58.14% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.09
vs STU:IX1: 2.83
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
IDEXX Laboratories OCF Yield % Related Terms
IDEXX Laboratories OCF Yield % Historical Data
* Premium members only.
The historical data trend for IDEXX Laboratories's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, IDEXX Laboratories's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEXX Laboratories OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's OCF Yield % distribution charts can be found below:
* The bar in red indicates where IDEXX Laboratories's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories (STU:IX1) has a OCF Yield % of 2.83 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on IDEXX Laboratories and its competitors. This is 40% above median its historical median of 2.02. Over the past decade, IDEXX Laboratories' OCF Yield % has ranged from 1.28 to 3.48. According to the industry distribution chart, IDEXX Laboratories ranks #90 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 41.9%.
Is IDEXX Laboratories' OCF Yield % too high?
IDEXX Laboratories' current OCF Yield % of 2.83 is 40% above median its 10-year median of 2.02. Over the past 10 years, this metric has ranged from a low of 1.28 to a high of 3.48. The Medical Diagnostics & Research industry median OCF Yield % is 1.09. IDEXX Laboratories' value of 2.83 is 159.6% above this industry median. Based on the distribution chart, IDEXX Laboratories ranks #90 out of 215 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, IDEXX Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' OCF Yield % compare to A and WAT?
According to the Medical Diagnostics & Research industry distribution chart, IDEXX Laboratories ranks #90 out of 215 companies for OCF Yield %. This puts IDEXX Laboratories in the upper half of its industry. The industry median OCF Yield % is 1.09. IDEXX Laboratories' value of 2.83 is 159.6% above this benchmark. Historically, IDEXX Laboratories' own OCF Yield % has ranged from 1.28 to 3.48 over the past decade. While the company's 10-year median is 2.02 vs. the industry median of 1.09, IDEXX Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 1.09, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDEXX Laboratories's current OCF Yield % of 2.83 is 159.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on IDEXX Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 1.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDEXX Laboratories's current OCF Yield % is 2.83, which is 40% above median its own 10-year median of 2.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
Based on GuruFocus' analysis, IDEXX Laboratories (STU:IX1) is currently considered Modestly Undervalued. The stock's GF Value™ is €553.33, compared to a current price of €475.00 — trading 14.2% below its estimated fair value. The current OCF Yield % is 2.83, which is 40% above median its 10-year median of 2.02 and 159.6% above the Medical Diagnostics & Research industry median of 1.09. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For IDEXX Laboratories (STU:IX1), the current OCF Yield % is 2.83 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDEXX Laboratories (STU:IX1) Overvalued in 2026?
Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued.
The current stock price of €475.00 is trading 14.2% below its estimated GF Value™ of €553.33.
GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.
Key valuation signals for STU:IX1:
OCF Yield %: 2.83 (40% above median its 10-year median of 2.02)
GF Value™: €553.33 vs. price of €475.00 (14.2% below fair value)
Industry Position: 159.6% above the Medical Diagnostics & Research median (#90 of 215)
No single metric tells the full story. See the STU:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score
Get the complete analysis for STU:IX1
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:IX1 has been successfully added to your 
